Login to Your Account

SGX Stock Plummets After Troxatyl Fails In Phase II/III

By Aaron Lorenzo

Wednesday, August 30, 2006
Shares in SGX Pharmaceuticals Inc. suffered mightily on Tuesday following a Phase II/III study stoppage. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription